Penn Vet | Research Stories
New Bolton Center Kennett Square, PA
Emergencies & Appointments:
Ryan Hospital Philadelphia, PA

University of Pennsylvania Researcher Earns 100,000 Grant

By: Carl Alston | (847) 919-6250 | Date: Jul 30, 2019

Dr. Andres Blanco, center, confers with his lab.

Dr. Andres Blanco, center, confers with his lab. The grant is one of 12 awarded by the Leukemia Research Foundation.

[NORTHFIELD, Ill., July 30, 2019] -- The Leukemia Research Foundation is proud to announce a grant of $100,000 in blood cancer research funding to M. Andres Blanco, Ph.D. from the University of Pennsylvania’s School of Veterinary Medicine in Philadelphia, PA, for the research project titled Dual Targeting of LSD1 and KAT6A to Induce Therapeutic Differentiation in AML. The one-year grant is awarded through the Foundation’s Hollis Brownstein Research Grants Program for New Investigators.

“The primary mission of the Leukemia Research Foundation is to fund research into the causes of and cures for blood cancers and providing grants to New Investigators is critically important,” said Leukemia Research Foundation Executive Director Kevin Radelet.

“Each year, federal funding becomes more difficult to secure and New Investigators with fresh, groundbreaking ideas can’t get the funding they need to develop their ideas and the data required for greater funding from the National Institutes of Health (NIH) and other sources. Leukemia Research Foundation funding not only advances blood cancer science but also jumpstarts careers for these scientists.”

Each proposal was thoroughly evaluated and scored using the same scoring system adhered to by the NIH. The Leukemia Research Foundation Medical Advisory Board, led by Patrick J. Stiff, M.D., medical director of the Cardinal Bernardin Cancer Center at Loyola University Medical center in Maywood, Ill., discussed each project in person that scored in the top half of the preliminary critique. Final recommendations were forwarded to the Leukemia Research Foundation for funding.

Additional research grant recipients include the following:

Stephanie O. Berg, D.O. – Cardinal Bernardin Cancer Center,
Loyola University Medical Center (Maywood, Illinois)

Hamza Celik, Ph.D. – Washington University School of Medicine (St. Louis, Missouri)

Steven M. Chan, M.D., Ph.D. – Princess Margaret Cancer Centre (Toronto, Canada)

Raffaella Di Micco, Ph.D. – Ospedale San Raffaele (Milan, Italy)

Daichi Inoue, M.D., Ph.D. – Institute of Biomedical Research and Innovation (IBRI)
(Kobe City, Japan)

Irum Khan, M.D. –University of Illinois at Chicago (Chicago, Illinois)

Yongsoo Kim, Ph.D. – VU University (Amsterdam, Netherlands)

Rui Lu, Ph.D. – University of Alabama (Birmingham, Alabama)

Michael Milyavsky, Ph.D. – Tel Aviv University (Tel Aviv, Israel)

Christopher Ott, Ph.D. – Massachusetts General Hospital (Charlestown, Massachusetts)

Capucine Van Rechem, Ph.D. – Stanford University (Stanford, California)

The Leukemia Research Foundation has funded more than 500 research projects on five continents since 1946. Funding for the FY 2019-2020 cycle began July 1, 2019. For more information about the Leukemia Research Foundation and its Hollis Brownstein Research Grants Program, visit or call 847-424-0600.

About The Leukemia Research Foundation (LRF)

The Leukemia Research Foundation, a 4-Star Charity headquartered in Northfield, Ill., is committed to funding research and providing support to people affected by blood cancers. The Leukemia Research Foundation is dedicated to conquering all blood cancers by funding research into their causes and cures, and enriching the quality of life of those touched by these diseases. For 73 years, thousands of volunteers and 22 current volunteer chapters have helped the Foundation raise more than $80 million to help fund research specifically targeting aspiring, eager, and innovative scientists and physicians around the world, provide patient financial assistance, and offer educational and emotional support for patients and their families.

Leukemia Research Foundation information is available at, or by calling 847-424-0600.